Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Cantor Fitzgerald Reiterates Overweight Rating on NeuroPace Inc (NPCE)
-
Cantor Fitzgerald Reiterates Overweight Rating on NeuroPace Inc (NPCE)
-
Cantor Fitzgerald Pounding Table on NeuroPace Inc (NPCE): 'we would be buyers of NPCE on today's pullback'
-
Cantor Fitzgerald Reiterates Overweight Rating on NeuroPace Inc (NPCE)
-
NeuroPace Inc (NPCE) PT Lowered to $17 at Cantor Fitzgerald
-
NeuroPace Inc (NPCE) PT Lowered to $17 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on NeuroPace Inc (NPCE)
-
Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer
-
NeuroPace Inc (NPCE) PT Maintained at $20 at Cantor Fitzgerald
-
NeuroPace Inc (NPCE) PT Raised to $20 at Cantor Fitzgerald
-
NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
NeuroPace (NPCE) Announces Pricing of Public Offering of $65M of Common Stock
-
NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock
-
NeuroPace (NPCE) Announces $65M Proposed Share Offering
-
NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock
-
Cantor Fitzgerald Starts NeuroPace Inc (NPCE) at Overweight, 'Wired for Success'
-
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
